Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 15738503)

Published in Br J Psychiatry on March 01, 2005

Authors

Siegfried Kasper1, Dan J Stein, Henrik Loft, Rico Nil

Author Affiliations

1: Department of General Psychiatry, University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. sci-genpsy@meduniwien.ac.at

Articles citing this

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry (2014) 1.39

Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study. BMC Psychiatry (2010) 0.93

Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population. J Psychiatr Res (2012) 0.90

Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol (2008) 0.90

Pregabalin influences insula and amygdala activation during anticipation of emotional images. Neuropsychopharmacology (2011) 0.86

Optimal treatment of social phobia: systematic review and meta-analysis. Neuropsychiatr Dis Treat (2012) 0.83

INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALS. Depress Anxiety (2015) 0.78

Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters. Horm Behav (2012) 0.78

Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials. Psychopharmacology (Berl) (2010) 0.77

Resistant social anxiety disorder response to Escitalopram. Clin Pract Epidemiol Ment Health (2006) 0.77

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2007) 0.76

Escitalopram for social anxiety disorder. Br J Psychiatry (2005) 0.75

Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players. Front Synaptic Neurosci (2017) 0.75

Articles by these authors

Grand challenges in global mental health. Nature (2011) 8.40

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry (2007) 6.46

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med (2008) 4.01

Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS (2008) 3.24

Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05

Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry (2011) 3.01

Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain (2007) 2.95

The South Africa Stress and Health Study: rationale and design. Metab Brain Dis (2004) 2.68

Psychopathology and coping in recently diagnosed HIV/AIDS patients--the role of gender. S Afr Med J (2003) 2.66

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64

Social anxiety disorder. Lancet (2008) 2.49

Treatment of suicidal people around the world. Br J Psychiatry (2011) 2.34

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry (2008) 2.12

Drop out from out-patient mental healthcare in the World Health Organization's World Mental Health Survey initiative. Br J Psychiatry (2012) 2.09

Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety (2010) 2.00

The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J (2009) 1.99

Problematic internet use: proposed classification and diagnostic criteria. Depress Anxiety (2003) 1.86

Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety (2010) 1.85

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res (2008) 1.84

Social determinants of psychological distress in a nationally-representative sample of South African adults. Soc Sci Med (2008) 1.83

The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization. J Clin Psychiatry (2006) 1.70

Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68

The epidemiology of major depression in South Africa: results from the South African stress and health study. S Afr Med J (2009) 1.64

Community attitudes toward and knowledge of mental illness in South Africa. Soc Psychiatry Psychiatr Epidemiol (2003) 1.63

Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev (2009) 1.63

Symptomatology and psychopathology of mental health problems after disaster. J Clin Psychiatry (2006) 1.63

Perceived discrimination, race and health in South Africa. Soc Sci Med (2008) 1.62

Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study. J Psychosom Res (2006) 1.61

A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. J Clin Psychiatry (2005) 1.61

The role of criterion A2 in the DSM-IV diagnosis of posttraumatic stress disorder. Biol Psychiatry (2010) 1.60

Multiple traumatic events and psychological distress: the South Africa stress and health study. J Trauma Stress (2007) 1.60

Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication. Psychol Med (2005) 1.59

Pharmacological interventions for preventing post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev (2014) 1.57

Barriers to mental health care and predictors of treatment dropout in the South African Stress and Health Study. Psychiatr Serv (2011) 1.56

Towards a genuinely medical model for psychiatric nosology. BMC Med (2012) 1.54

Cumulative effect of multiple trauma on symptoms of posttraumatic stress disorder, anxiety, and depression in adolescents. Compr Psychiatry (2008) 1.54

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol (2010) 1.54

What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? J Clin Psychiatry (2006) 1.48

Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety (2010) 1.47

Trauma and posttraumatic stress disorder in an urban Xhosa primary care population: prevalence, comorbidity, and service use patterns. J Nerv Ment Dis (2003) 1.46

The relation between multiple pains and mental disorders: results from the World Mental Health Surveys. Pain (2007) 1.46

Intimate partner violence, health behaviours, and chronic physical illness among South African women. S Afr Med J (2010) 1.45

Pharmacotherapy for anxiety and comorbid alcohol use disorders. Cochrane Database Syst Rev (2015) 1.44

Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol (2011) 1.43

Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med (2005) 1.41

Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors? Biol Psychiatry (2007) 1.40

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol (2003) 1.34

Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav (2011) 1.33

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. Int J Neuropsychopharmacol (2011) 1.32

Non-fatal suicidal behavior among South Africans : results from the South Africa Stress and Health Study. Soc Psychiatry Psychiatr Epidemiol (2008) 1.31

Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav (2009) 1.29

Cumulative traumas and risk thresholds: 12-month PTSD in the World Mental Health (WMH) surveys. Depress Anxiety (2013) 1.28

Risk for post-traumatic stress disorder associated with different forms of interpersonal violence in South Africa. Soc Sci Med (2008) 1.27

Patterns of substance use in South Africa: results from the South African Stress and Health study. S Afr Med J (2009) 1.26

Gender differences in risk for intimate partner violence among South African adults. J Interpers Violence (2010) 1.26

Optimizing mental health services in low-income and middle-income countries. Curr Opin Psychiatry (2011) 1.25

Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder. Psychopathology (2003) 1.25

Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats. Metab Brain Dis (2009) 1.24

Traditional healers in the treatment of common mental disorders in South Africa. J Nerv Ment Dis (2009) 1.23

Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry (2003) 1.20

Culture and the anxiety disorders: recommendations for DSM-V. Depress Anxiety (2010) 1.18

Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder. Int Clin Psychopharmacol (2014) 1.17

Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety (2010) 1.15

Life stress and mental disorders in the South African stress and health study. S Afr Med J (2009) 1.15

Physical violence against intimate partners and related exposures to violence among South African men. CMAJ (2008) 1.15

Comparing the accuracy of brief versus long depression screening instruments which have been validated in low and middle income countries: a systematic review. BMC Psychiatry (2012) 1.13

Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. J Anxiety Disord (2006) 1.13

Treatment of obsessive-compulsive disorder by U.S. psychiatrists. J Clin Psychiatry (2006) 1.13

The child and adolescent trichotillomania impact project: descriptive psychopathology, comorbidity, functional impairment, and treatment utilization. J Dev Behav Pediatr (2008) 1.13

Impulse control disorders and "behavioural addictions" in the ICD-11. World Psychiatry (2014) 1.12

The neuropsychiatry and neuropsychology of lipoid proteinosis. J Neuropsychiatry Clin Neurosci (2008) 1.12

Self-help and Internet-guided interventions in depression and anxiety disorders: a systematic review of meta-analyses. CNS Spectr (2009) 1.11

Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS (2011) 1.11

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry (2006) 1.10

Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet (2010) 1.10

A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD). Eur Neuropsychopharmacol (2011) 1.09

Posttraumatic stress disorder: acquisition, recognition, course, and treatment. J Neuropsychiatry Clin Neurosci (2004) 1.09

A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder. J Psychopharmacol (2012) 1.09

Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram. BMC Psychiatry (2004) 1.08

Linking posttraumatic stress disorder and psychosis: a look at epidemiology, phenomenology, and treatment. J Nerv Ment Dis (2003) 1.08

Mental health service use among South Africans for mood, anxiety and substance use disorders. S Afr Med J (2009) 1.08

Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety (2010) 1.07

WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr (2003) 1.06

The trichotillomania scale for children: development and validation. Child Psychiatry Hum Dev (2008) 1.05

Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.05

Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS Behav (2013) 1.05

Synergistic tonic and phasic activity of the locus coeruleus norepinephrine (LC-NE) arousal system is required for optimal attentional performance. Metab Brain Dis (2012) 1.04

Post-traumatic stress disorder in women: epidemiological and treatment issues. CNS Drugs (2005) 1.04

Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Compr Psychiatry (2005) 1.03

Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev (2009) 1.02

Interventions for educating traditional healers about STD and HIV medicine. Cochrane Database Syst Rev (2009) 1.02

Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor. J Affect Disord (2004) 1.02

Prevalence and correlates of non-fatal suicidal behaviour among South Africans. Br J Psychiatry (2008) 1.02

Childhood trauma in obsessive-compulsive disorder, trichotillomania, and controls. Depress Anxiety (2002) 1.01

Impulsive disorders in Japanese adult patients with obsessive-compulsive disorder. Compr Psychiatry (2005) 1.01

Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder. J Affect Disord (2013) 1.01

Developmental trauma is associated with behavioral hyperarousal, altered HPA axis activity, and decreased hippocampal neurotrophin expression in the adult rat. Ann N Y Acad Sci (2006) 1.01